# Stent: Interventions

Source page: https://www.materialinsights.org/products/p_stent/prod-interventions/

#### Interventions

Changes that would cut emissions or material use, by lever and life stage, with effect per unit, readiness, adoption, evidence and who acts

| Lever | Life stage | Change | Effect per unit | Readiness | Adoption | Who acts | Source |
|---|---|---|---|---|---|---|---|
| Design | Components design | Thinner struts in cobalt-chromium and platinum-chromium stents | Struts of 50 to 90 µm against 130 to 150 µm in stainless steel stents ^[2]; a lower metal mass is likely but no source gives a stent mass | Deployed | New-generation drug-eluting stents have the thinner struts ^[2] | Stent makers | ^[2] |
| Substitute | Components design | Dissolving scaffolds in place of permanent metal | No permanent metal is left, but the Absorb's struts were 150 µm against 81 µm for the Xience ^[6], and its development was reported to have failed to achieve further clinical benefits ^[5] | Piloted and set back (CE mark January 2011, FDA approval July 2016 ^[7]) | Not given in any source opened | Stent makers, regulators | ^[6]^[5]^[7] |
| Substitute | Use | Pathway footprint: a study of one Australian hospital cohort found the whole stenting pathway had a lower footprint than the bypass surgery pathway | 2.4 tonnes CO2e per stenting procedure, against 11.5 tonnes for bypass surgery, in 29 stenting patients at one Sydney hospital; a per-procedure figure for the whole pathway, not per stent, and not a basis for choosing a treatment, which rests on clinical need ^[18] | Deployed (both procedures in routine use) | Not given in any source opened | Clinicians and hospitals | ^[18] |

as of 2026-11-13

#### Sources

1. [State of the art: coronary artery stents – past, present and future](https://eurointervention.pcronline.com/article/state-of-the-art-coronary-artery-stents-past-present-and-future/pdf) EuroIntervention (Stefanini, Byrne, Windecker and Kastrati), 2017, EuroIntervention 2017;13:706-716
2. [Modern Stents: Where Are We Going?](https://rmmj.org.il/issues/45/1080/manuscript) Rambam Maimonides Medical Journal (Kobo and others), 2020, RMMJ 2020;11(2):e0017, DOI 10.5041/RMMJ.10403
3. [Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry](https://scielo.isciii.es/pdf/recic/v6n4/en_2604-7306-recic-6-4-321.pdf) REC: Interventional Cardiology 6(4):321-331 (Macaya-Ten, Gonzalo, Escaned, Macaya), 2024
4. [The Surprising History Behind an Extremely Common Cardiovascular Medical Device](https://www.mddionline.com/cardiovascular/the-surprising-history-behind-an-extremely-common-cardiovascular-medical-device) MD+DI, no byline or date shown on the page
5. [Healthcare-related carbon footprinting—lower impact of a coronary stenting compared to a coronary surgery pathway](https://www.frontiersin.org/articles/10.3389/fpubh.2024.1386826/full) Frontiers in Public Health, volume 12 (Sack and others), 2024, published 21 August 2024; Royal Prince Alfred Hospital, Sydney; 29 stenting patients, 2021 to 2022

## Other sections

- [Summary](https://www.materialinsights.org/products/p_stent/index.md)
- [Working](https://www.materialinsights.org/products/p_stent/prod-working/index.md)
- [Bill of materials](https://www.materialinsights.org/products/p_stent/prod-bom/index.md)
- [Use case](https://www.materialinsights.org/products/p_stent/prod-use/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_stent/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_stent/prod-footprint/index.md)
- [Evolution](https://www.materialinsights.org/products/p_stent/prod-evolution/index.md)
